Back to Search
Start Over
Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study
- Source :
- Leukemia. 35:3626-3626
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 14765551 and 08876924
- Volume :
- 35
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi...........67e7ffdf85ef845fa99ff0cdb9de88be
- Full Text :
- https://doi.org/10.1038/s41375-021-01396-x